Extensive R&D Inpeptide for Novel Drugs will Escalate the North American Peptide Therapeutics Market

The North American peptide therapeutics market will see a considerable growth of 5.1% during the forecast period. The region has a significant presence of peptide therapeutics manufacturers, with extensive R&D in the peptide therapeutics market. The Peptide Therapeutics Foundation, a not-for-profit 501C (3) was also established in 2008 in the region with the intention to promote R&D of peptide therapeutics. 

The Foundation and Symposium are supported by global companies such as Ferring Research Institute Inc., AstraZeneca, the PolyPeptide Group, Novo Nordisk, and Zealand Pharma. This is also anticipated to present new growth opportunities for the companies in the region working in the peptide therapeutics market.

Browse the full report description of "North American Peptide Therapeutics Market Size, Share & Trends Analysis Report, By Route of Administration (Oral and Parenteral), by Application (Cancer, Metabolic Disorder, Gastrointestinal Disorders, Central Nervous System Disorders, Respiratory Disorders, and Others), Forecast 2020-2026" at https://www.omrglobal.com/industry-reports/north-american-peptide-therapeutics-market

Concerning peptide therapeutics, the number of research and studies has also been increasing. According to the US FDA, as of March 2017, nearly 40 drugs had obtained approval in the US, Europe, and Japan. In addition, 155 peptides were in active clinical development. 2018 had been a decent one for peptides, with the US FDA approving 5 peptides and 1 peptidomimetic, collectively accounting for about 13% of overall drugs accepted that year. Individual targets have rapidly increased in popularity due to the success of a first-in-class peptide, resulting in numerous follow-on research programs pursuing the same mechanism.

Market Coverage

Key questions addressed by the report

• What is the market growth rate during the forecast period?
• Which segment/region dominates the market in the base year?
• Which segment/region will project the fastest growth in the market during the forecast period?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

North American Peptide Therapeutics Market – Segmentation

By Route of Administration

• Oral
• Parenteral

By Application

• Cancer
• Metabolic Disorder
• Gastrointestinal Disorders
• Central Nervous System Disorders
• Respiratory Disorders
• Others (Kidney Disorder and Autoimmune Disorder)

North American Peptide Therapeutics Market – Segmentation by Geography

• US
• Canada